Cisen Pharmaceutical Co., Ltd.
603367.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.65B
Close$
$17.89
24.8% upside
Current Fair Value
24.8% upsideUndervalued by 24.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.65 Billion |
|---|---|
| Enterprise Value | $5.70 Billion |
| Dividend Yield | $0.35 (2.56%) |
| Earnings per Share | $0.93 |
| Beta | 0.15 |
| Outstanding Shares | 452,754,129 |
Return
| Return on Equity | 7.15% |
|---|---|
| Return on Assets | 5.83% |
| Return on Invested Capital | 4.30% |
Valuation & Multiples
| P/E Ratio | 14.44 |
|---|---|
| PEG | 25.71 |
| Price to Sales | 2.05 |
| Price to Book Ratio | 1.02 |
| Enterprise Value to Revenue | 1.68 |
| Enterprise Value to EBIT | 20.2 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cisen Pharmaceutical Co., Ltd.
3,114 employees
CEO: Zhenxin Du Cisen Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise, manufacturing and distributing a diverse portfolio of chemical drug preparations and healthcare products to both domestic and international markets. Founded in 1998 ...